Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

First Report of Bilateral Pheochromocytoma in the Clinical Spectrum of<i>HIF2A</i>-Related Polycythemia-Paraganglioma Syndrome

29 Mar 2013

Abstract excerpt

CONTEXT: Molecular genetic research has so far resulted in the identification of 10 well-characterized susceptibility genes for hereditary pheochromocytoma (PHEO) or paraganglioma (PGL). Recently, a new syndrome characterized by multiple PGLs and somatostatinomas associated with congenital polycythemia due to somatic mutations in HIF2A has been reported. OBJECTIVE: The aim of the study was to define the genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal and Paraganglionic Tumors
Share to Cancer, Hypoxia, and Metabolism
Share to Pituitary Gland Disorders and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23539726
DOI: 10.1210/jc.2013-1217

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

First Report of Bilateral Pheochromocytoma in the Clinical Spectrum of<i>HIF2A</i>-Related Polycythemia-Paraganglioma SyndromePMID 23539726Read ↗

Polycythemia and Paraganglioma With a Novel Somatic <i>HIF2A</i> Mutation in a MaleSemantic proximity Read ↗

Nonmosaic somatic HIF2A mutations associated with late onset polycythemia‐paraganglioma syndrome: Newly recognized subclass of polycythemia‐paraganglioma syndromeSemantic proximity Read ↗

Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas.Semantic proximity Read ↗

A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paragangliomaSemantic proximity Read ↗

Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia.Semantic proximity Read ↗

Pacak–Zhuang syndrome: a model providing new insights into tumor syndromesSemantic proximity Read ↗

A new twist in neuroendocrine tumor research: Pacak-Zhuang syndrome, HIF-2α as the major player in its pathogenesis and future therapeutic options.Semantic proximity Read ↗

Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas.Semantic proximity Read ↗

A Novel EPO Gene Mutation In a Family With Autosomal Dominant PolycythemiaSemantic proximity Read ↗

Novel Germline PHD2 Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia.Semantic proximity Read ↗

HIF Signaling Pathway in Pheochromocytoma and Other Neuroendocrine TumorsSemantic proximity Read ↗

The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/ParagangliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.